HEADER HYDROLASE/HYDROLASE INHIBITOR 23-MAR-00 1EOJ TITLE DESIGN OF P1' AND P3' RESIDUES OF TRIVALENT THROMBIN INHIBITORS AND TITLE 2 THEIR CRYSTAL STRUCTURES COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA THROMBIN; COMPND 3 CHAIN: A; COMPND 4 EC: 3.4.21.5; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: THROMBIN INHIBITOR P798; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 MOL_ID: 2; SOURCE 6 SYNTHETIC: YES; SOURCE 7 OTHER_DETAILS: THIS SEQUENCE WAS CHEMICALLY SYNTHESIZED KEYWDS THROMBIN INHIBITORS, SERINE PROTEASE, HYDROLASE-HYDROLASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.J.SLON-USAKIEWICZ,J.SIVARAMAN,Y.LI,M.CYGLER,Y.KONISHI REVDAT 7 15-NOV-23 1EOJ 1 SEQADV LINK ATOM REVDAT 6 04-OCT-17 1EOJ 1 REMARK REVDAT 5 13-JUL-11 1EOJ 1 VERSN REVDAT 4 21-JUL-09 1EOJ 1 HETATM REVDAT 3 24-FEB-09 1EOJ 1 VERSN REVDAT 2 10-MAY-00 1EOJ 1 REMARK REVDAT 1 03-MAY-00 1EOJ 0 JRNL AUTH J.J.SLON-USAKIEWICZ,J.SIVARAMAN,Y.LI,M.CYGLER,Y.KONISHI JRNL TITL DESIGN OF P1' AND P3' RESIDUES OF TRIVALENT THROMBIN JRNL TITL 2 INHIBITORS AND THEIR CRYSTAL STRUCTURES. JRNL REF BIOCHEMISTRY V. 39 2384 2000 JRNL REFN ISSN 0006-2960 JRNL PMID 10694407 JRNL DOI 10.1021/BI992419B REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.843 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.8 REMARK 3 NUMBER OF REFLECTIONS : 18421 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.233 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2006 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2380 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 160 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.718 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1EOJ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-APR-00. REMARK 100 THE DEPOSITION ID IS D_1000010770. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-MAR-96 REMARK 200 TEMPERATURE (KELVIN) : 298.0 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IIC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20426 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 45.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.300 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 18.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.17 REMARK 200 COMPLETENESS FOR SHELL (%) : 73.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.13000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.62 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, POTASSIUM SULFATE, CITRIC REMARK 280 ACID PH 5.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 35.40000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 35.40000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 36.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 14L REMARK 465 GLY A 14M REMARK 465 ARG A 14N REMARK 465 THR A 146A REMARK 465 TRP A 146B REMARK 465 THR A 146C REMARK 465 ALA A 146D REMARK 465 ASN A 146E REMARK 465 VAL A 146F REMARK 465 GLY A 146G REMARK 465 LYS A 146H REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ARG B 2 N ARG B 2 CA 0.125 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 37 C - N - CA ANGL. DEV. = -11.2 DEGREES REMARK 500 ARG A 75 NE - CZ - NH1 ANGL. DEV. = 4.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 7 -85.01 -127.32 REMARK 500 SER A 36A -104.29 -59.72 REMARK 500 GLN A 38 93.87 -47.17 REMARK 500 ASN A 60G 87.49 -160.34 REMARK 500 HIS A 71 -50.43 -135.98 REMARK 500 ASN A 78 -1.68 74.86 REMARK 500 GLU A 97A -67.96 -123.65 REMARK 500 SER A 115 -167.12 -164.28 REMARK 500 SER A 214 -85.94 -102.72 REMARK 500 CPI B 3 156.89 104.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF THROMBIN INHIBITOR REMARK 800 P798 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1IHS RELATED DB: PDB REMARK 900 THROMBIN - HIRUTONIN-2 COMPLEX REMARK 900 RELATED ID: 1EOL RELATED DB: PDB DBREF 1EOJ A 1D 245 UNP P00734 THRB_HUMAN 332 620 DBREF 1EOJ B 1 14 PDB 1EOJ 1EOJ 1 14 SEQADV 1EOJ GLY A 1C UNP P00734 GLU 333 CONFLICT SEQRES 1 A 289 GLY GLY ALA ASP CYS GLY LEU ARG PRO LEU PHE GLU LYS SEQRES 2 A 289 LYS SER LEU GLU ASP LYS THR GLU ARG GLU LEU LEU GLU SEQRES 3 A 289 SER TYR ILE ASP GLY ARG ILE VAL GLU GLY SER ASP ALA SEQRES 4 A 289 GLU ILE GLY MET SER PRO TRP GLN VAL MET LEU PHE ARG SEQRES 5 A 289 LYS SER PRO GLN GLU LEU LEU CYS GLY ALA SER LEU ILE SEQRES 6 A 289 SER ASP ARG TRP VAL LEU THR ALA ALA HIS CYS LEU LEU SEQRES 7 A 289 TYR PRO PRO TRP ASP LYS ASN PHE THR GLU ASN ASP LEU SEQRES 8 A 289 LEU VAL ARG ILE GLY LYS HIS SER ARG THR ARG TYR GLU SEQRES 9 A 289 ARG ASN ILE GLU LYS ILE SER MET LEU GLU LYS ILE TYR SEQRES 10 A 289 ILE HIS PRO ARG TYR ASN TRP ARG GLU ASN LEU ASP ARG SEQRES 11 A 289 ASP ILE ALA LEU MET LYS LEU LYS LYS PRO VAL ALA PHE SEQRES 12 A 289 SER ASP TYR ILE HIS PRO VAL CYS LEU PRO ASP ARG GLU SEQRES 13 A 289 THR ALA ALA SER LEU LEU GLN ALA GLY TYR LYS GLY ARG SEQRES 14 A 289 VAL THR GLY TRP GLY ASN LEU LYS GLU THR TRP THR ALA SEQRES 15 A 289 ASN VAL GLY LYS GLY GLN PRO SER VAL LEU GLN VAL VAL SEQRES 16 A 289 ASN LEU PRO ILE VAL GLU ARG PRO VAL CYS LYS ASP SER SEQRES 17 A 289 THR ARG ILE ARG ILE THR ASP ASN MET PHE CYS ALA GLY SEQRES 18 A 289 TYR LYS PRO ASP GLU GLY LYS ARG GLY ASP ALA CYS GLU SEQRES 19 A 289 GLY ASP SER GLY GLY PRO PHE VAL MET LYS SER PRO PHE SEQRES 20 A 289 ASN ASN ARG TRP TYR GLN MET GLY ILE VAL SER TRP GLY SEQRES 21 A 289 GLU GLY CYS ASP ARG ASP GLY LYS TYR GLY PHE TYR THR SEQRES 22 A 289 HIS VAL PHE ARG LEU LYS LYS TRP ILE GLN LYS VAL ILE SEQRES 23 A 289 ASP GLN PHE SEQRES 1 B 14 BBS ARG CPI TIH DOA ASP TYR GLU PRO ILE PRO GLU GLU SEQRES 2 B 14 ALA MODRES 1EOJ TIH B 4 ALA BETA(2-THIENYL)ALANINE HET BBS B 1 13 HET CPI B 3 8 HET TIH B 4 10 HET DOA B 5 14 HETNAM BBS 4-TERT-BUTYLBENZENESULFONIC ACID HETNAM CPI 6-CARBOXYPIPERIDINE HETNAM TIH BETA(2-THIENYL)ALANINE HETNAM DOA 12-AMINO-DODECANOIC ACID FORMUL 2 BBS C10 H14 O3 S FORMUL 2 CPI C6 H11 N O2 FORMUL 2 TIH C7 H9 N O2 S FORMUL 2 DOA C12 H25 N O2 FORMUL 3 HOH *160(H2 O) HELIX 1 1 PHE A 7 SER A 11 5 5 HELIX 2 3 ALA A 55 CYS A 58 5 4 HELIX 3 6 ASP A 125 LEU A 130 1 9 HELIX 4 7 GLU A 164 ASP A 170 1 7 HELIX 5 9 LEU A 234 PHE A 245 1 12 SHEET 1 A 7 SER A 20 ASP A 21 0 SHEET 2 A 7 GLN A 156 PRO A 161 -1 N VAL A 157 O SER A 20 SHEET 3 A 7 LYS A 135 GLY A 140 -1 N GLY A 136 O LEU A 160 SHEET 4 A 7 PRO A 198 LYS A 202 -1 O PRO A 198 N THR A 139 SHEET 5 A 7 TRP A 207 TRP A 215 -1 N TYR A 208 O MET A 201 SHEET 6 A 7 GLY A 226 HIS A 230 -1 N PHE A 227 O TRP A 215 SHEET 7 A 7 MET A 180 ALA A 183 -1 O PHE A 181 N TYR A 228 SHEET 1 B 7 GLN A 30 ARG A 35 0 SHEET 2 B 7 GLU A 39 LEU A 46 -1 O GLU A 39 N ARG A 35 SHEET 3 B 7 TRP A 51 THR A 54 -1 N LEU A 53 O SER A 45 SHEET 4 B 7 ALA A 104 LEU A 108 -1 O ALA A 104 N THR A 54 SHEET 5 B 7 LYS A 81 ILE A 90 -1 N GLU A 86 O LYS A 107 SHEET 6 B 7 LEU A 64 ILE A 68 -1 O LEU A 64 N LEU A 85 SHEET 7 B 7 GLN A 30 ARG A 35 -1 O MET A 32 N ARG A 67 SHEET 1 C 2 LEU A 60 TYR A 60A 0 SHEET 2 C 2 LYS A 60F ASN A 60G-1 O LYS A 60F N TYR A 60A SSBOND 1 CYS A 1 CYS A 122 1555 1555 2.03 SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.03 SSBOND 3 CYS A 168 CYS A 182 1555 1555 2.03 SSBOND 4 CYS A 191 CYS A 220 1555 1555 2.03 LINK S BBS B 1 N ARG B 2 1555 1555 1.55 LINK C CPI B 3 N TIH B 4 1555 1555 1.34 LINK C TIH B 4 N DOA B 5 1555 1555 1.33 LINK C DOA B 5 N ASP B 6 1555 1555 1.33 CISPEP 1 ARG B 2 CPI B 3 0 -0.86 SITE 1 AC1 28 GLN A 38 GLU A 39 LEU A 40 LEU A 41 SITE 2 AC1 28 HIS A 57 TRP A 60D LYS A 60F ARG A 73 SITE 3 AC1 28 THR A 74 ARG A 75 TYR A 76 ILE A 82 SITE 4 AC1 28 GLU A 97A LEU A 99 ASP A 189 ALA A 190 SITE 5 AC1 28 GLU A 192 SER A 195 SER A 214 TRP A 215 SITE 6 AC1 28 GLY A 216 GLY A 219 HOH A 272 HOH A 282 SITE 7 AC1 28 HOH A 374 HOH B 47 HOH B 49 HOH B 89 CRYST1 70.800 72.000 72.900 90.00 100.20 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014124 0.000000 0.002541 0.00000 SCALE2 0.000000 0.013889 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013938 0.00000